/

Identified versus Statistical Lives An Interdisciplinary Perspective

Cohen I. Glenn Daniels Norman Eyal Nir
Innbundet / 2015 / Engelsk

Produktdetaljer

ISBN
9780190217471
Publisert
2015
Utgiver
Oxford University Press Inc
Vekt
454 gr
Høyde
163 mm
Bredde
236 mm
Dybde
23 mm
Aldersnivå
UP, P, 05, 06
Språk
Product language
Engelsk
Format
Product format
Innbundet
Antall sider
240

Redaktør
Cohen I. Glenn
Daniels Norman
Eyal Nir

Biografisk notat

I. Glenn Cohen is Professor of Law at Harvard Law School, and Director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. Norman Daniels Daniels is the Mary B. Saltonstall Professor and Professor of Ethics and Population Health at the Harvard School of Public Health. Nir Eyal Associate Professor of Global Health and Social Medicine (Medical Ethics) at the Harvard Medical School. He is the co-editor of INEQUALITIES IN HEALTH (OUP, 2013) and the co-editor of the Population-Level Bioethics series.

Identified versus Statistical Lives An Interdisciplinary Perspective

Cohen I. Glenn Daniels Norman Eyal Nir
Innbundet / 2015 / Engelsk
Cohen I. Glenn Daniels Norman Eyal Nir
Innbundet / 2015 / Engelsk
1.069,-
Laveste pris siste 30 dager: 1.069,-
Levering 10-30 dager
Klikk og hent
On August 5, 2010, a cave-in left thirty-three Chilean miners trapped underground. The Chilean government embarked on a massive rescue effort that is estimated to have cost between ten and twenty million dollars. There is a puzzle here. Many mine safety measures that would have been more cost effective had not been taken in Chile earlier, either by the mining companies, the Chilean government or by international donors. The Chilean story illustrates a persistent puzzle: the identified lives effect. Human beings show a greater inclination to assist persons and groups identified as those at high risk of great harm than to assist persons and groups who will suffer -- or already suffer -- similar harm but are not identified as yet. The problem touches almost every aspect of human life and politics: health, the environment, the law. What can social and cognitive sciences teach us about the origin and triggers of the effect? Philosophically and ethically, is the effect a "bias" to be eliminated or is it morally justified? What implications does the effect have for health care, law, the environment and other practice domains? This volume is the first book to tackle the effect from all necessary perspectives: psychology, public health, law, ethics, and public policy.
Les mer
Human beings show a greater inclination to assist persons identified as being at high risk of great harm than to assist persons who will suffer similar harm but are not identified as yet. Does this effect constitute a virtue, or a vice? What explains the effect? What are the implications for policy?
Les mer
Acknowledgments ; Contributors ; I. Glenn Cohen, Norman Daniels, and Nir Eyal, Statistical versus Identified Persons: An Introduction ; Part I: Social Science ; Chapter 1 ; Deborah A. Small, On the Psychology of the Identifiable Victim Effect ; Chapter 2 ; Peter Railton, <"Dual-Process>" Models of the Mind and the <"Statistical Victim Effect>" ; Part II: Ethics and Political Philosophy ; Chapter 3 ; Dan W. Brock, Identified vs. Statistical Lives: Some Introductory Issues and Arguments ; Chapter 4 ; Matthew Adler, Welfarism, Equity, and the Choice Between Statistical and Identified Victims ; Chapter 5 ; Michael Otsuka, Risking Life and Limb: How to Discount Harms by Their Improbability ; Chapter 6 ; Nir Eyal, Concentrated Risk, the Coventry Blitz, Chamberlain's Cancer ; Chapter 7 ; Norman Daniels, Can There Be Moral Force to Favoring an Identified over a Statistical Life? ; Chapter 8 ; Caspar Hare, Statistical People and Counterfactual Indeterminacy ; Chapter 9 ; Marcel Verweij, How (Not) to Argue for the Rule of Rescue: Claims of Individuals versus Group Solidarity ; Chapter 10 ; Michael Slote, Why Not Empathy? ; Part III: Applications ; Chapter 11 ; I. Glenn Cohen, Identified versus Statistical Lives in U.S. Civil Litigation: Of Standing, Ripeness, and Class Actions ; Chapter 12 ; Lisa Heinzerling, Statistical Lives in Environmental Law ; Chapter 13 ; Johann Frick, Treatment versus Prevention in the Fight against HIV/AIDS and the Problem of Identified versus Statistical Lives ; Chapter 14 ; Till Barnighausen and Max Essex, From Biology to Policy: Ethical and Economic Issues in HIV Treatment-as-Prevention ; Chapter 15 ; Jonathan Wolff, Testing, Treating, and Trusting
Les mer
Selling point: The first volume on the subject of the identified lives effect, a topic of hot debate Selling point: Examines the implications for policy Selling point: An interdisciplinary study of the subject
Les mer
I. Glenn Cohen is Professor of Law at Harvard Law School, and Director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. Norman Daniels Daniels is the Mary B. Saltonstall Professor and Professor of Ethics and Population Health at the Harvard School of Public Health. Nir Eyal Associate Professor of Global Health and Social Medicine (Medical Ethics) at the Harvard Medical School. He is the co-editor of INEQUALITIES IN HEALTH (OUP, 2013) and the co-editor of the Population-Level Bioethics series.
Les mer
Selling point: The first volume on the subject of the identified lives effect, a topic of hot debate Selling point: Examines the implications for policy Selling point: An interdisciplinary study of the subject
Les mer

Relaterte produkter

On August 5, 2010, a cave-in left thirty-three Chilean miners trapped underground. The Chilean government embarked on a massive rescue effort that is estimated to have cost between ten and twenty million dollars. There is a puzzle here. Many mine safety measures that would have been more cost effective had not been taken in Chile earlier, either by the mining companies, the Chilean government or by international donors. The Chilean story illustrates a persistent puzzle: the identified lives effect. Human beings show a greater inclination to assist persons and groups identified as those at high risk of great harm than to assist persons and groups who will suffer -- or already suffer -- similar harm but are not identified as yet. The problem touches almost every aspect of human life and politics: health, the environment, the law. What can social and cognitive sciences teach us about the origin and triggers of the effect? Philosophically and ethically, is the effect a "bias" to be eliminated or is it morally justified? What implications does the effect have for health care, law, the environment and other practice domains? This volume is the first book to tackle the effect from all necessary perspectives: psychology, public health, law, ethics, and public policy.
Les mer
Human beings show a greater inclination to assist persons identified as being at high risk of great harm than to assist persons who will suffer similar harm but are not identified as yet. Does this effect constitute a virtue, or a vice? What explains the effect? What are the implications for policy?
Les mer
Acknowledgments ; Contributors ; I. Glenn Cohen, Norman Daniels, and Nir Eyal, Statistical versus Identified Persons: An Introduction ; Part I: Social Science ; Chapter 1 ; Deborah A. Small, On the Psychology of the Identifiable Victim Effect ; Chapter 2 ; Peter Railton, <"Dual-Process>" Models of the Mind and the <"Statistical Victim Effect>" ; Part II: Ethics and Political Philosophy ; Chapter 3 ; Dan W. Brock, Identified vs. Statistical Lives: Some Introductory Issues and Arguments ; Chapter 4 ; Matthew Adler, Welfarism, Equity, and the Choice Between Statistical and Identified Victims ; Chapter 5 ; Michael Otsuka, Risking Life and Limb: How to Discount Harms by Their Improbability ; Chapter 6 ; Nir Eyal, Concentrated Risk, the Coventry Blitz, Chamberlain's Cancer ; Chapter 7 ; Norman Daniels, Can There Be Moral Force to Favoring an Identified over a Statistical Life? ; Chapter 8 ; Caspar Hare, Statistical People and Counterfactual Indeterminacy ; Chapter 9 ; Marcel Verweij, How (Not) to Argue for the Rule of Rescue: Claims of Individuals versus Group Solidarity ; Chapter 10 ; Michael Slote, Why Not Empathy? ; Part III: Applications ; Chapter 11 ; I. Glenn Cohen, Identified versus Statistical Lives in U.S. Civil Litigation: Of Standing, Ripeness, and Class Actions ; Chapter 12 ; Lisa Heinzerling, Statistical Lives in Environmental Law ; Chapter 13 ; Johann Frick, Treatment versus Prevention in the Fight against HIV/AIDS and the Problem of Identified versus Statistical Lives ; Chapter 14 ; Till Barnighausen and Max Essex, From Biology to Policy: Ethical and Economic Issues in HIV Treatment-as-Prevention ; Chapter 15 ; Jonathan Wolff, Testing, Treating, and Trusting
Les mer
Selling point: The first volume on the subject of the identified lives effect, a topic of hot debate Selling point: Examines the implications for policy Selling point: An interdisciplinary study of the subject
Les mer
I. Glenn Cohen is Professor of Law at Harvard Law School, and Director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. Norman Daniels Daniels is the Mary B. Saltonstall Professor and Professor of Ethics and Population Health at the Harvard School of Public Health. Nir Eyal Associate Professor of Global Health and Social Medicine (Medical Ethics) at the Harvard Medical School. He is the co-editor of INEQUALITIES IN HEALTH (OUP, 2013) and the co-editor of the Population-Level Bioethics series.
Les mer
Selling point: The first volume on the subject of the identified lives effect, a topic of hot debate Selling point: Examines the implications for policy Selling point: An interdisciplinary study of the subject
Les mer

Produktdetaljer

ISBN
9780190217471
Publisert
2015
Utgiver
Oxford University Press Inc
Vekt
454 gr
Høyde
163 mm
Bredde
236 mm
Dybde
23 mm
Aldersnivå
UP, P, 05, 06
Språk
Product language
Engelsk
Format
Product format
Innbundet
Antall sider
240

Redaktør
Cohen I. Glenn
Daniels Norman
Eyal Nir

Biografisk notat

I. Glenn Cohen is Professor of Law at Harvard Law School, and Director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. Norman Daniels Daniels is the Mary B. Saltonstall Professor and Professor of Ethics and Population Health at the Harvard School of Public Health. Nir Eyal Associate Professor of Global Health and Social Medicine (Medical Ethics) at the Harvard Medical School. He is the co-editor of INEQUALITIES IN HEALTH (OUP, 2013) and the co-editor of the Population-Level Bioethics series.

Relaterte produkter